SCHEMBL20759869

SCHEMBL20759869

CON(C)C(=O)c1cnc(C2=CCNCC2)nc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ QDPR P09417 3/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36
▸ CCNT1 O60563 3/20 0.35
▸ CDK9 P50750 3/20 0.35
▸ SIGMAR1 Q99720 2/20 0.34
▸ GABRP O00591 1/20 0.34
▸ GABRD O14764 1/20 0.34
▸ GABRA1 P14867 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ GABRB1 P18505 1/20 0.34
▸ GABRG2 P18507 1/20 0.34
▸ GABRR1 P24046 1/20 0.34
▸ GABRB3 P28472 1/20 0.34
▸ GABRA5 P31644 1/20 0.34
▸ GABRA3 P34903 1/20 0.34
▸ GABRA2 P47869 1/20 0.34
▸ GABRB2 P47870 1/20 0.34
▸ GABRA4 P48169 1/20 0.34
▸ GABRE P78334 1/20 0.34
▸ GABRA6 Q16445 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL26983272 0.92 MLYCD (0.36) QDPRHRH3CCNT1CDK9SIGMAR1
SCHEMBL31701401 0.81 HRH3 (0.36) QDPRHRH3CCNT1CDK9SIGMAR1
SCHEMBL29531318 0.78 GABRP (0.49) QDPRHRH3CCNT1CDK9SIGMAR1
SCHEMBL29766145 0.75 RXFP1 (0.48) HTR2CLMNA
SCHEMBL15024196 0.75 HTR6 (0.45) QDPRHRH3CCNT1CDK9SIGMAR1
SCHEMBL28364566 0.73 ALDH1A1 (0.36) QDPRHRH3CCNT1CDK9TSHR
SCHEMBL15001446 0.73 HRH3 (0.46) QDPRHRH3SIGMAR1HTR2CTGFBR1
SCHEMBL31701883 0.72 WNT3A (0.42) QDPRHRH3CCNT1CDK9SIGMAR1
SCHEMBL20760623 0.70 NPC1 (0.44) QDPRCCNT1CDK9SIGMAR1HTR2C
SCHEMBL31702391 0.70 CDK4 (0.37) QDPRHRH3CCNT1CDK9SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110891953-B Pyrrolotriazines derivatives, preparation method and application thereof 浙江海正药业股份有限公司 2022-07-12 — — CN disclosed
WO-2022081627-A1 COMPOSITIONS AND METHODS FOR TREATING KIT-AND PDGFRA-MEDIATED DISEASES BLUEPRINT MEDICINES CORPORATION (US) 2022-04-21 — — WO disclosed
CN-110891953-A Pyrrolotriazines derivatives, preparation method and application thereof 浙江海正药业股份有限公司 2020-03-17 — — CN disclosed
WO-2019034128-A1 PYRROLOTRIAZINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF 浙江海正药业股份有限公司 2019-02-21 — — WO disclosed
Send feedback